Rosiglitazone therapy of posttransplant diabetes mellitus

Transplantation

Volumn 80, Issue 10, 2005, Pages 1402-1405

  Villanueva, Griselda ^a   Baldwin, David ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Hyperglycemia; Insulin; Posttransplant diabetes mellitus; Thiazolidenediones

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; INSULIN; INSULIN SENSITIZING AGENT; ISOPHANE INSULIN; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; DIABETES MELLITUS; EDEMA; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HOME MONITORING; HUMAN; INSULIN DEPENDENCE; INSULIN TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG CONGESTION; MALE; MONOTHERAPY; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTTRANSPLANTATION DIABETES MELLITUS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; AGED; CYCLOSPORINE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PPAR GAMMA; PROSPECTIVE STUDIES; TACROLIMUS; THIAZOLIDINEDIONES;

EID: 29144443855     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000181165.19788.95     Document Type: Article

References (26)

1. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes. Diabetes Care 2002; 25: 583.
2. Maes BD, Kuypers D, Messiaen T, et al. Posttranplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001; 72: 1655.
3. Hagen M, Hjelmesaeth J, Jenssen T, et al. A 6-year prospective study on new diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003; 18: 2154.
4. Hjelmesaeth J, Medtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation. Diabetes Care 2001; 24: 2121.
5. Johnson C, Ahsan N, Gonwa T, et al. Randomized trial of tacrolimus (Prograf) in comination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69: 834.
6. Davidson J, Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines. Diabetes Care 2004; 27: 805.
7. Kaplan B, Friedman G, Jacobs M, et al. Potential interaction of troglitizone and cyclosporine. Transplantation 1998; 65: 1399.
8. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004; 351: 1106.
9. Nowak SN, Edwards DJ, Clarke A, et al. Pioglitizone: effect on CYP3A4 activity. J Clin Pharmacol 2002; 42: 1299.
10. Willi SM, Kennedy A, Brant BP, et al. Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes. Diabetes Res 2002; 58: 87.
11. Willi SM, Kennedy A, Wallace P, et al. Troglitazone antagonizes metabolic effects of glucocorticoids in humans. Diabetes 2002; 51: 2895.
12. Luther P, Baldwin D. Pioglitazone in the management of diabetes mellitus after transplantation. Am J Transplant 2004; 4: 2135.
13. Baldwin D, Duftin K. Rosiglitazone treatment of diabetes mellitus after solid organ transplantation. Transplantation 2004; 77: 1009.
14. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183.
15. Kasiske B, Snyder J, Gilbertson D, Matas A. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
16. Delgado-Borrego A, Casson D, Schoenfeld D, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004; 77: 703.
17. Mathew JT, Rao M, Job V, et al. Post-transplant hyperglycemia: a study of risk factors. Nephrol Dial Transplant 2003; 18: 164.
18. First RM, Gerber DA, Hariharan S, et al. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation 2002; 73: 379.
19. Schwimmer J, Zand MS. Management of diabetes mellitus after solid organ transplantation. Graft 2001; 4: 256.
20. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440.
21. Hjelmesaeth J, Hartmann A, Midtvedt K, et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dialysis Transplant 2003; 16: 1047.
22. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transplant 2002; 8: 708.
23. Nampoory MR, Johny KV, Costandi JN, et al. Inferior long-term outcome of renal transplantation in patients with diabetes mellitus. Med Principles Pract 2002; 11: 29.
24. Revanur VK, Jardine AG, Kingsmore DB, et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 89.
25. Lindholm A, Albrechtsen D, Frodin L, et al. Ischemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60: 451.
26. Mudaliar S, Henry R. New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers. Ann Rev Med 2001; 52: 239.